Tuoxin Pharmaceutical Group (301089.SZ) has had its application for issuing stocks to specific targets accepted by the Shenzhen Stock Exchange.
Tuo Xin Pharmaceuticals (301089.SZ) announced that it has recently received a notice from the Shenzhen Stock Exchange regarding the acceptance of the application documents for the issuance of shares to specific objects. The Shenzhen Stock Exchange has verified the application documents for the issuance of shares to specific objects for the fiscal year 2026 submitted by the company, and has deemed the application documents complete, thus deciding to accept the application.
Tuoxin Pharmaceutical Group (301089.SZ) announced that it recently received a notice from the Shenzhen Stock Exchange regarding the acceptance of its application for issuance of shares to specific targets (Shenzhen Stock Exchange Review [2026] No. 240). The Shenzhen Stock Exchange reviewed the application documents submitted by the company for the issuance of shares to specific targets in 2026 and determined that the application documents were complete, deciding to accept them.
Related Articles
Verisilicon Microelectronics (Shanghai) Co., Ltd. (688521.SH) plans to introduce a restricted stock incentive plan in 2026.
Beijing InHand Networks Technology (688080.SH) plans to repurchase shares worth 20 million to 30 million yuan.
Sino Medical Sciences Technology Inc. (688108.SH) subsidiary's self-expanding intracranial drug-coated stent system has obtained EU MDR certification.
Verisilicon Microelectronics (Shanghai) Co., Ltd. (688521.SH) plans to introduce a restricted stock incentive plan in 2026.
Beijing InHand Networks Technology (688080.SH) plans to repurchase shares worth 20 million to 30 million yuan.
Sino Medical Sciences Technology Inc. (688108.SH) subsidiary's self-expanding intracranial drug-coated stent system has obtained EU MDR certification.
RECOMMEND
